Patent · US Expired

1,2-Diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof

US7550498B2 · kind B2 · utility

0Cited by
11References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 20, 2003
Grant dateJun 23, 2009
Priority date
Expiry dateDec 24, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to derivatives of 1,2-diaza-dibenzoazulene, to their pharmacologically acceptable salts and solvates, to processes and intermediates for the preparation thereof as well as to their antiinflammatory actions, especially to the inhibition of tumor necrosis factor-α (TNF-α) production and the inhibition of interleukin-1 (IL-1) production as well as to their analgetic action.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.